Evidence map›Paper›PMID 29467660›Full record

ReviewFrontiers in pharmacology2018

Advantages and Limitations of Current Imaging Techniques for Characterizing Liposome Morphology.

Annie-Louise Robson, Paul C Dastoor, Jamie Flynn, William Palmer, Antony Martin, Doug W Smith, Ameha Woldu, Susan Hua

Abstract readReview
In one paragraph

Review in Frontiers in pharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Advances in MoSBiosensors · 2025
    Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Annie-Louise RobsonSchool of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia.
Paul C DastoorCentre for Organic Electronics, University of Newcastle, Callaghan, NSW, Australia.
Jamie FlynnSchool of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia.
William PalmerHunter Medical Research Institute, New Lambton Heights, NSW, Australia.
Antony MartinHunter Medical Research Institute, New Lambton Heights, NSW, Australia.
Doug W SmithSchool of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia.
Ameha WolduHunter Medical Research Institute, New Lambton Heights, NSW, Australia.
Susan HuaSchool of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There are currently a number of imaging techniques available for evaluating the morphology of liposomes and other nanoparticles, with each having its own advantages and disadvantages that should be considered when interpreting data. Controlling and validating the morphology of nanoparticles is of key importance for the effective clinical translation of liposomal formulations. There are a number of physical characteristics of liposomes that determine their

Indexed as

atomic-force microscopyelectron microscopyimaginglight microscopyliposomesmicroscopynanoparticles

Identifiers

PMID29467660
PMCPMC5808202

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.